edoxaban tosylate(DU-176b)
DU176b-D-U305
Phase 3 small_molecule completed
Quick answer
edoxaban tosylate(DU-176b) for Venous Thromboembolism is a Phase 3 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo
- Indication
- Venous Thromboembolism
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed